[
  {
    "section": "section:1",
    "title": "A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer"
  },
  {
    "section": "section:2",
    "title": "PATIENTS AND METHODS"
  },
  {
    "section": "section:3",
    "title": "Patients"
  },
  {
    "section": "section:3",
    "title": "Study Design and Treatment Plan"
  },
  {
    "section": "section:3",
    "title": "Safety Assessments"
  },
  {
    "section": "section:3",
    "title": "Pharmacokinetic Measurements and Analyses"
  },
  {
    "section": "section:3",
    "title": "Assessment of Tumor Response"
  },
  {
    "section": "section:3",
    "title": "Statistical Analyses"
  },
  {
    "section": "section:2",
    "title": "RESULTS"
  },
  {
    "section": "section:3",
    "title": "Patient Characteristics"
  },
  {
    "section": "section:3",
    "title": "Dose Administration"
  },
  {
    "section": "section:3",
    "title": "Toxicities"
  },
  {
    "section": "section:3",
    "title": "Treatment Response"
  },
  {
    "section": "section:3",
    "title": "Pharmacokinetics"
  },
  {
    "section": "section:2",
    "title": "DISCUSSION"
  },
  {
    "section": "section:2",
    "title": "ACKNOWLEDGMENTS"
  },
  {
    "section": "section:2",
    "title": "REFERENCES"
  }
]